Skip to main content
Caplight Logo









Immuto Scientific

Immuto Scientific

Private
Madison, WisconsinHealthcare & Life Scienceshttps://immutoscientific.com/

Last Round

Seed

Sep 18, 2025

Total Funding Raised

$16.14M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Immuto Scientific is a biotechnology company that provides analytical research services for drug discovery using its proprietary platform for protein structural analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

protein structural analysisdrug discoverycontract research organizationCROepitope mappingstructural proteomicsmass spectrometryprotein-ligand interactionsAI drug discoverymolecular dynamicsantibody refinementsurfaceomicsin silico drug designbiotech R&Dtherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Immuto Scientific Comparables

Compare Immuto Scientific with similar companies based on industry and business-model similarity.

Immuto Scientific comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CovalX
79%
A-Alpha Bio
79%
Bruker
67%

Immuto Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 18, 2025
GrantAug 15, 2022
SeedOct 12, 2021
SeedSep 1, 2021
GrantMar 10, 2020

Key People

Founding team and executive leadership

Daniel Benjamin

Co-Founder, Chief Technology Officer

Founding Team

Faraz A. Choudhury

Co-founder And CEO

Founding Team

Immuto Scientific Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 447% MoM, from 51 to 279.

  • Sep 18, 2025

    Partnered with Daiichi Sankyo Co. Ltd. on drug discovery.

Immuto Scientific Filings

Explore SEC and related filing metadata, where available.

Immuto Scientific filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Immuto Scientific's valuation, stock price, and market status.

Is Immuto Scientific a public or private company?

Immuto Scientific is a private company.

What is the current stock price of Immuto Scientific?

Immuto Scientific is a private company with no public stock price. No recent secondary market data is available.

How much is Immuto Scientific worth (valuation)?

Valuation information for Immuto Scientific is not publicly available.

Can I buy Immuto Scientific stock?

Immuto Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Immuto Scientific's last funding round?

Immuto Scientific's most recent funding round was Seed on September 18, 2025.

Who are the main investors in Immuto Scientific?

Key investors in Immuto Scientific include DYDX Capital, Wisconsin Investment Partners.

Will Immuto Scientific IPO soon?

No public IPO plans have been announced for Immuto Scientific.

How can I track Immuto Scientific secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Immuto Scientific's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMadison, Wisconsin
Employee Range14
Year Founded2021
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?